Skip to content
Independent analysis of NHS open data
PharmaInsight

Ledipasvir/sofosbuvir

Infections Antiviral drugs BNF 0503032F0
Data updated January 2022 Download CSV

Ledipasvir/sofosbuvir was dispensed in England in January 2022, with 1 items, down 50.0% on a year earlier.

1items -50%

Dispensed in January 2022

0items

Rolling 12 months

£1,392

Net ingredient cost · January 2022

Figure 1. Ledipasvir/sofosbuvir: national items dispensed by month

0 2 4 Jan 2021 Feb 2021 Mar 2021 Jun 2021 Nov 2021 Jan 2022 1 Jan 2021: 2 Feb 2021: 4 Mar 2021: 1 Jun 2021: 1 Nov 2021: 1 Jan 2022: 1

Source: NHSBSA Prescription Cost Analysis, to January 2022

Download CSV
Embed this chart

At a glance

  • Therapeutic class Antiviral drugs
  • Presentations 1 shown
  • Average cost / item £1,392.14
  • Year on year Down 50.0% on a year earlier
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, January 2022

The individual products dispensed under Ledipasvir/sofosbuvir this month.

Presentations of Ledipasvir/sofosbuvir, January 2022
Presentation BNF code Items Net ingredient cost
Harvoni 90mg/400mg tablets 0503032F0BBAAAA 1 £1,392

Source: NHSBSA Prescription Cost Analysis · to January 2022 OGL v3.0

Compare Ledipasvir/sofosbuvir with

Other medicines in the same BNF section, by prescribing volume.